Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio B Gonzalez

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Arthritis Care & Research|October 26, 2012
Measuring illness behavior in patients with systemic sclerosisErin L Merz, Vanessa L Malcarne, Scott C Roesch, et al.
Seminars in Arthritis and Rheumatism|March 25, 2011
Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohortRoozbeh Sharif, Maureen D Mayes, Perry M Nicassio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2017
Major Histocompatibility Complex Class II Alleles Influence Induction of Pathogenic Antiphospholipid Antibodies in a Mouse Model of ThrombosisElizabeth Papalardo, Zurina Romay-Penabad, Rohan Willis, et al.
Frontiers in Immunology|November 9, 2018
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid SyndromeThomas C R McDonnell, Rohan Willis, Charis Pericleous, et al.
The Journal of Rheumatology|April 17, 2013
Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis?Mona Elhaj, Julio Charles, Claudia Pedroza, et al.
American Journal of Clinical Pathology|March 17, 2018
Performance Evaluation and Clinical Associations of Immunoassays That Detect Antibodies to Negatively Charged Phospholipids Other Than CardiolipinAmaris Castanon, Grant Pierre, Rohan Willis, et al.
Annals of the Rheumatic Diseases|March 24, 2012
IRF5 polymorphism predicts prognosis in patients with systemic sclerosisRoozbeh Sharif, Maureen D Mayes, Filemon K Tan, et al.
The Journal of Rheumatology|May 17, 2011
Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysisRoozbeh Sharif, Marvin J Fritzler, Maureen D Mayes, et al.
Arthritis and Rheumatism|August 29, 2013
Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndromeVijaya Murthy, Rohan Willis, Zurina Romay-Penabad, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Arthritis Care & Research|October 26, 2012
Measuring illness behavior in patients with systemic sclerosisErin L Merz, Vanessa L Malcarne, Scott C Roesch, et al.
Seminars in Arthritis and Rheumatism|March 25, 2011
Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohortRoozbeh Sharif, Maureen D Mayes, Perry M Nicassio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2017
Major Histocompatibility Complex Class II Alleles Influence Induction of Pathogenic Antiphospholipid Antibodies in a Mouse Model of ThrombosisElizabeth Papalardo, Zurina Romay-Penabad, Rohan Willis, et al.
Frontiers in Immunology|November 9, 2018
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid SyndromeThomas C R McDonnell, Rohan Willis, Charis Pericleous, et al.
The Journal of Rheumatology|April 17, 2013
Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis?Mona Elhaj, Julio Charles, Claudia Pedroza, et al.
American Journal of Clinical Pathology|March 17, 2018
Performance Evaluation and Clinical Associations of Immunoassays That Detect Antibodies to Negatively Charged Phospholipids Other Than CardiolipinAmaris Castanon, Grant Pierre, Rohan Willis, et al.
Annals of the Rheumatic Diseases|March 24, 2012
IRF5 polymorphism predicts prognosis in patients with systemic sclerosisRoozbeh Sharif, Maureen D Mayes, Filemon K Tan, et al.
The Journal of Rheumatology|May 17, 2011
Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysisRoozbeh Sharif, Marvin J Fritzler, Maureen D Mayes, et al.
Arthritis and Rheumatism|August 29, 2013
Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndromeVijaya Murthy, Rohan Willis, Zurina Romay-Penabad, et al.
Pageof 3